Literature DB >> 33572297

Bioinformatic Approaches to Validation and Functional Analysis of 3D Lung Cancer Models.

P Jonathan Li1, Jeroen P Roose2, David M Jablons1, Johannes R Kratz1.   

Abstract

3D models of cancer have the potential to improve basic, translational, and clinical studies. Patient-derived xenografts, spheroids, and organoids are broad categories of 3D models of cancer, and to date, these 3D models of cancer have been established for a variety of cancer types. In lung cancer, for example, 3D models offer a promising new avenue to gain novel insights into lung tumor biology and improve outcomes for patients afflicted with the number one cancer killer worldwide. However, the adoption and utility of these 3D models of cancer vary, and demonstrating the fidelity of these models is a critical first step before seeking meaningful applications. Here, we review use cases of current 3D lung cancer models and bioinformatic approaches to assessing model fidelity. Bioinformatics approaches play a key role in both validating 3D lung cancer models and high dimensional functional analyses to support downstream applications.

Entities:  

Keywords:  3D cultures; bioinformatics; lung cancer; organoids; spheroids; xenografts

Year:  2021        PMID: 33572297      PMCID: PMC7915264          DOI: 10.3390/cancers13040701

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  66 in total

Review 1.  "Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy.

Authors:  Federico Garrido; Teresa Cabrera; Natalia Aptsiauri
Journal:  Int J Cancer       Date:  2010-07-15       Impact factor: 7.396

2.  Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.

Authors:  Ruoshi Shi; Nikolina Radulovich; Christine Ng; Ni Liu; Hirotsugu Notsuda; Michael Cabanero; Sebastiao N Martins-Filho; Vibha Raghavan; Quan Li; Arvind Singh Mer; Joshua C Rosen; Ming Li; Yu-Hui Wang; Laura Tamblyn; Nhu-An Pham; Benjamin Haibe-Kains; Geoffrey Liu; Nadeem Moghal; Ming-Sound Tsao
Journal:  Clin Cancer Res       Date:  2019-11-06       Impact factor: 12.531

3.  Immuno-oncology drug development goes global.

Authors:  Jia Xin Yu; Vanessa M Hubbard-Lucey; Jun Tang
Journal:  Nat Rev Drug Discov       Date:  2019-11       Impact factor: 84.694

Review 4.  Synthetic Immunology: Hacking Immune Cells to Expand Their Therapeutic Capabilities.

Authors:  Kole T Roybal; Wendell A Lim
Journal:  Annu Rev Immunol       Date:  2017-04-26       Impact factor: 28.527

5.  Human organoids: a new dimension in cell biology.

Authors:  Ruth Lehmann; Connie M Lee; Erika C Shugart; Marta Benedetti; R Alta Charo; Zev Gartner; Brigid Hogan; Jürgen Knoblich; Celeste M Nelson; Kevin M Wilson
Journal:  Mol Biol Cell       Date:  2019-05-01       Impact factor: 4.138

6.  Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening.

Authors:  Minsuh Kim; Hyemin Mun; Chang Oak Sung; Eun Jeong Cho; Hye-Joon Jeon; Sung-Min Chun; Da Jung Jung; Tae Hoon Shin; Gi Seok Jeong; Dong Kwan Kim; Eun Kyung Choi; Seong-Yun Jeong; Alison M Taylor; Sejal Jain; Matthew Meyerson; Se Jin Jang
Journal:  Nat Commun       Date:  2019-09-05       Impact factor: 14.919

7.  Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.

Authors:  Susan Tsai; Laura McOlash; Katie Palen; Bryon Johnson; Christine Duris; Qiuhui Yang; Michael B Dwinell; Bryan Hunt; Douglas B Evans; Jill Gershan; Michael A James
Journal:  BMC Cancer       Date:  2018-03-27       Impact factor: 4.430

Review 8.  Immune Cell Dynamics Unfolded by Single-Cell Technologies.

Authors:  Daniel J Kunz; Tomás Gomes; Kylie R James
Journal:  Front Immunol       Date:  2018-06-26       Impact factor: 7.561

Review 9.  Organoid Models of Tumor Immunology.

Authors:  Kanako Yuki; Ning Cheng; Michitaka Nakano; Calvin J Kuo
Journal:  Trends Immunol       Date:  2020-07-09       Impact factor: 16.687

10.  Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.

Authors:  Nicholas McGranahan; Rachel Rosenthal; Crispin T Hiley; Andrew J Rowan; Thomas B K Watkins; Gareth A Wilson; Nicolai J Birkbak; Selvaraju Veeriah; Peter Van Loo; Javier Herrero; Charles Swanton
Journal:  Cell       Date:  2017-10-26       Impact factor: 41.582

View more
  1 in total

1.  Immune Evasion as the Main Challenge for Immunotherapy of Cancer.

Authors:  Radoslaw Zagozdzon; Magdalena Winiarska; Malgorzata Firczuk
Journal:  Cancers (Basel)       Date:  2022-07-26       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.